CARY, N.C.–(September 21, 2016)–The CEO Roundtable on Cancer has accredited Focused Ultrasound Foundation in Charlottesville, VA, with the CEO Cancer Gold StandardTM, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer, a nonprofit organization of CEOs, founded by former President George H.W. Bush, developed and administers the Gold Standard, a workplace accreditation program which encourages and recognizes the commitment of organizations that take concrete actions to address cancer in their workplaces. Nearly 200 private, nonprofit and government employers in a wide range of occupational categories have earned Gold Standard accreditation, including the National Cancer Institute (NCI) and a number of NCI-designated cancer centers.
To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by taking concrete actions in five key areas: establishing policies and programs to reduce cancer risk by prohibiting tobacco use and supporting tobacco cessation efforts; promoting physical activity, healthy nutrition and weight management; providing health insurance options that include detecting cancer at its earliest stages, access to quality care and participation in cancer clinical trials; promoting employee awareness of these initiatives; and supporting the needs of cancer survivors in the workplace.
“We are pleased to recognize the efforts of Focused Ultrasound Foundation and their dedication to health care that begins with improving the health and wellness of their own employees,” said Robert A. Bradway, chairman and chief executive officer of Amgen and chairman of the CEO Roundtable on Cancer.
“Our organization is driven to advancing focused ultrasound as a non-invasive alternative or complement to traditional approaches for treating a range of devastating cancers,” said Foundation Chairman Neal Kassell, MD. “And we recognize that the best weapon against cancer is good health and prevention, so we are honored to have our dedication to wellness recognized by the CEO Roundtable on Cancer.”
In addition to the NCI and the Centers for Disease Control and Prevention (CDC), 16 NCI-designated cancer centers and more than 100 other hospitals have earned Gold Standard accreditation. CEOs from many industries are keenly aware of the life-improving impact they can have on health and controlling healthcare costs when they address cancer and other chronic diseases. Gold Standard employers include: Avis Budget Group, Harvard T.H. Chan School of Public Health, Lowe’s, Amgen, State Farm, Hogan Lovells, Dell, Johnson & Johnson, Novartis, SAS and many Blue Cross affiliates.
About Focused Ultrasound Foundation
The Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development of focused ultrasound, an early-stage noninvasive therapeutic technology with the potential to transform the treatment of many serious medical disorders, including cancers of the brain, breast, pancreas, liver, prostate, soft tissue tumors and others. The Foundation works to clear the path to global adoption by coordinating and funding research, fostering collaboration and building awareness among patients and professionals. Since its establishment in 2006, the Foundation has become the largest non-governmental source of funding for focused ultrasound research. More information can be found at www.fusfoundation.org.
The CEO Roundtable on Cancer, a nonprofit organization of CEOs, founded by former President George H.W. Bush, developed and administers the Gold Standard, a workplace accreditation program which encourages and recognizes the commitment of organizations that take concrete actions to address cancer in their workplaces. Nearly 200 private, nonprofit and government employers in a wide range of occupational categories have earned Gold Standard accreditation, including the National Cancer Institute (NCI) and a number of NCI-designated cancer centers.
To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by taking concrete actions in five key areas: establishing policies and programs to reduce cancer risk by prohibiting tobacco use and supporting tobacco cessation efforts; promoting physical activity, healthy nutrition and weight management; providing health insurance options that include detecting cancer at its earliest stages, access to quality care and participation in cancer clinical trials; promoting employee awareness of these initiatives; and supporting the needs of cancer survivors in the workplace.
“We are pleased to recognize the efforts of Focused Ultrasound Foundation and their dedication to health care that begins with improving the health and wellness of their own employees,” said Robert A. Bradway, chairman and chief executive officer of Amgen and chairman of the CEO Roundtable on Cancer.
“Our organization is driven to advancing focused ultrasound as a non-invasive alternative or complement to traditional approaches for treating a range of devastating cancers,” said Foundation Chairman Neal Kassell, MD. “And we recognize that the best weapon against cancer is good health and prevention, so we are honored to have our dedication to wellness recognized by the CEO Roundtable on Cancer.”
In addition to the NCI and the Centers for Disease Control and Prevention (CDC), 16 NCI-designated cancer centers and more than 100 other hospitals have earned Gold Standard accreditation. CEOs from many industries are keenly aware of the life-improving impact they can have on health and controlling healthcare costs when they address cancer and other chronic diseases. Gold Standard employers include: Avis Budget Group, Harvard T.H. Chan School of Public Health, Lowe’s, Amgen, State Farm, Hogan Lovells, Dell, Johnson & Johnson, Novartis, SAS and many Blue Cross affiliates.
About Focused Ultrasound Foundation
The Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development of focused ultrasound, an early-stage noninvasive therapeutic technology with the potential to transform the treatment of many serious medical disorders, including cancers of the brain, breast, pancreas, liver, prostate, soft tissue tumors and others. The Foundation works to clear the path to global adoption by coordinating and funding research, fostering collaboration and building awareness among patients and professionals. Since its establishment in 2006, the Foundation has become the largest non-governmental source of funding for focused ultrasound research. More information can be found at www.fusfoundation.org.